Concepedia

Wanlu Xu

WX

Statistics

Publications

2

Citations

142

H-Index

2

Active since

2013

Affiliations

Institut de Recherche en Cancérologie de Montpellier(Current)

Wanlu Xu is an author at Institut de Recherche en Cancérologie de Montpellier specializing in medicine, prognostic assessment, and geriatric emergencies.

ORCID

Publications per year

2013–2017

2

Publications

2

Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion

Jing Wang, Natalie W. Pursell, Maria Samson et al. · Molecular Cancer Therapeutics · 2013 · 83 citations

, , +17

The “Surprise Question” Asked of Emergency Physicians May Predict 12-Month Mortality among Older Emergency Department Patients

Kei Ouchi, Guru Jambaulikar, Naomi George et al. · Journal of Palliative Medicine · 2017 · 59 citations

, , +17

1–2 of 2